UTRGV Advances Cancer Nanotech Research with SG100 Electrospinning System
Since 2020, UTRGV researchers have been using the Spingenix SG100-CCS1000 electrospinning system to support cancer nanomedicine development. Now, backed by a $2.8M grant from the Cancer Prevention and Research Institute…
read more